Order results by:
| Issue | Title | |
| Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
| O. A. Shavlovskaya | ||
| "... . The groups of drugs widely used in clinical practice are disease-modifying osteoarthritis drugs (DMOADs ..." | ||
| Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... The review examines pharmacological agents that can have potential disease-modifying ..." | ||
| Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... (SYSADOAs), disease-modifying osteoarthritis drugs, between which an equal sign cannot be placed. According ..." | ||
| Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... acting drugs for osteoarthritis (SYSADOAs), disease-modifying osteoarthritis drugs, between which ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
| A. V. Rudakova, Т. V. Korotaeva | ||
| "... biological (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs), available ..." | ||
| Vol 18, No 1 (2025) | Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis | Abstract similar documents |
| S. A. Doktorova, Yu. Yu. Grabovetskaya, A. V. Zuev, J. N. Aksenova-Sorokhtei, V. V. Rafalskiy | ||
| "... ) and psoriatic arthritis (PsA) necessitates a detailed analysis of the consumption of disease-modifying ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system | Abstract similar documents |
| A. V. Rudakova, I. Z. Gaydukova | ||
| "... spondylitis (AS) in comparison with other biological disease-modifying antirheumatic drugs (bDMARDs) currently ..." | ||
| Vol 14, No 2 (2021) | Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region | Abstract similar documents |
| A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin | ||
| "... of patients suffering from severe asthma (SA) that require the prescription of biologic disease-modifying ..." | ||
| Vol 12, No 4 (2019) | Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis | Abstract similar documents |
| I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva | ||
| "... containing chondroitin sulfate or modifying its biosynthesis in patients with stage II knee osteoarthritis ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract similar documents |
| A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
| "... biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic disease-modifying ..." | ||
| Vol 15, No 1 (2022) | Application of chondroprotective agents to inhibit osteodestructive processes in the subchondral bone in patients with osteoarthritis | Abstract PDF (Eng) similar documents |
| О. А. Gromova, А. М. Lila, I. Yu. Torshin, I. А. Reier | ||
| "... затрагивать костной ткани, непосредственно прилегающей к хрящу сустава. Цель: систематический анализ научной ..." | ||
| Vol 11, No 3 (2018) | Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review | Abstract similar documents |
| D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin | ||
| "... ; the intervention – ocrelizumab; the comparators – all disease-modifying treatments for MS; the outcomes ..." | ||
| Vol 5, No 1 (2012) | EСOLOGO-ECONOMIC PROBLEMS OF TECHNOGENIC INFLUENCE OF POLLUTION ON DISEASE OF THE POPULATION | Abstract similar documents |
| A. I. Borodin, E. M. Ovchinnikov | ||
| Vol 16, No 1 (2023) | Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients | Abstract similar documents |
| I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova | ||
| Vol 9, No 2 (2016) | PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION | Abstract similar documents |
| T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva | ||
| "... in particular of providing preferential medicines patients with сhronic obstructive pulmonary disease (COPD ..." | ||
| Vol 14, No 4 (2021) | Economic burden of chronic viral hepatitis C | Abstract similar documents |
| R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova | ||
| "... of patients. Therefore, an important task remains to assess the global economic burden of the disease, taking ..." | ||
| Vol 16, No 3 (2023) | The role of ferritin in liver disease assessment | Abstract similar documents |
| V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik | ||
| "... Background. Ferritin is an important integral and diagnostic marker of liver diseases. In 1/3 ..." | ||
| Vol 11, No 4 (2018) | Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease | Abstract similar documents |
| V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev | ||
| "... Fabry disease (FD) is a severe lysosome storage disease caused by congenital deficiency ..." | ||
| Vol 14, No 3 (2021) | The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure | Abstract similar documents |
| M. V. Putilina, N. V. Teplova, O. S. Gerasimova | ||
| "... Osteoarthritis is considered a peripheral joint disease and is often ignored when discussing ..." | ||
| Vol 8, No 3 (2015) | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL | Abstract similar documents |
| D. V. Blinov | ||
| "... Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important ..." | ||
| Vol 14, No 4 (2021) | Machine learning based on laboratory data for disease prediction | Abstract similar documents |
| A. V. Gusev, R. E. Novitskiy, A. A. Ivshin, A. A. Alekseev | ||
| "... ", "clinical events", "prediction diseases"), CyberLeninka ("machine learning", "laboratory data", "clinical ..." | ||
| Vol 10, No 4 (2017) | PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. Yu. Frolov, V. A. Rogov | ||
| "... to a reduction in expenses associated with negative outcomes of the disease (endoprosthetics, disability, etc ..." | ||
| Vol 7, No 2 (2014) | ECONOMIC ANALYSIS OF USE OF IMMUNOCORRECTIVE PREPARATIONS FOR PREVENTION OF OFTEN RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS AT CHILDREN OF SCHOOL AGE | Abstract similar documents |
| R. V. Maiorov, D. P. Derbenev | ||
| "... infections and considerable decrease direct and indirect cost on treatment of respiratory infectious diseases ..." | ||
| Vol 13, No 4 (2020) | The social-economic burden of spinal muscular atrophy in Russia | Abstract similar documents |
| A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina | ||
| "... congenital orphan diseases that lead to progressive spinal motoneurons degeneration and loss ..." | ||
| Vol 12, No 1 (2019) | Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation | Abstract similar documents |
| T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko | ||
| "... Diseases of the musculoskeletal system and connective tissues are becoming more and more common ..." | ||
| Vol 13, No 3 (2020) | Economic burden of systemic sclerosis: systematic review | Abstract similar documents |
| D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin | ||
| "... Background. Systemic sclerosis (SSc) is a severe orphan disease, one of the systemic pathologies ..." | ||
| Vol 14, No 3 (2021) | Increasing the medico-economic efficiency of preventive counseling for patients with arterial hypertension and behavioral risk factors for non-communicable diseases | Abstract similar documents |
| O. L. Zadvornaya, A. N. Pishchita | ||
| "... -economic efficiency of the prevention of cardiovascular diseases (CVDs). Material and methods. A total ..." | ||
| Vol 14, No 3 (2021) | An economic evaluation of pre-dialysis stage of chronic kidney disease | Abstract similar documents |
| E. I. Rumiantseva, M. V. Avxentyeva | ||
| "... disease (CKD) and the cost-effectiveness of medical interventions used to detect CKD and prevent its ..." | ||
| Vol 7, No 4 (2014) | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY | Abstract similar documents |
| D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
| "... diseases. The analysis was conducted on the basis of 1499 selected trade procedures on rare disease drugs ..." | ||
| Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract similar documents |
| V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
| "... financing of rare disease drugs remains a serious problem for both foreign countries and our ..." | ||
| Vol 9, No 2 (2016) | PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS | Abstract similar documents |
| E. E. Vidyakina, S. V. Malchikova | ||
| "... Objective. To determine the priority used to vital drugs in сhronic obstructive pulmonary disease ..." | ||
| Vol 15, No 4 (2022) | Antibiotic resistance of uropathogens in patients with nephrolithiasis and concomitant coronary heart disease | Abstract similar documents |
| R. V. Royuk, S. K. Yarovoy, I. B. Shikina | ||
| "... their antibiotic resistance in patients with nephrolithiasis combined with coronary heart disease (CHD). Material ..." | ||
| Vol 14, No 2 (2021) | Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA | Abstract similar documents |
| E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev | ||
| "... Objective: identification of the relationship between the news coverage of global diseases ..." | ||
| Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract similar documents |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| "... with orphan diseases, included in the list of orphan diseases (24 diseases) by the RF Government Regulation ..." | ||
| Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract similar documents |
| D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
| "... Chronic liver diseases are a serious problem and a common cause of suffering and death in all ..." | ||
| Vol 8, No 2 (2015) | REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS | Abstract similar documents |
| Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev | ||
| "... Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal ..." | ||
| Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
| G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
| "... The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases ..." | ||
| Vol 13, No 4 (2020) | Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm | Abstract similar documents |
| M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov | ||
| Vol 14, No 3 (2021) | Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines | Abstract similar documents |
| I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva | ||
| "... diseases and to identify the main trends in the implementation of the federal program for the provision ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital | Abstract similar documents |
| L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva | ||
| "... drugs included in the standards of pharmacotherapy for rheumatic diseases. According to VEN analysis all ..." | ||
| Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
| I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
| "... publications on the relationship between CS/GS/UC-II and tumor diseases found by the query “(glucosamine ..." | ||
| Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
| V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
| "... for the local treatment of infectious and inflammatory diseases of oral cavity and oropharynx. Material ..." | ||
| Vol 5, No 1 (2012) | COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS | Abstract similar documents |
| R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko | ||
| "... consists in calculation of the expenses connected any given disease, without notice of effectiveness ..." | ||
| Vol 5, No 2 (2012) | COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS | Abstract similar documents |
| A. V. Rudakova | ||
| "... paricalcitoldecreases proteinuria in patients with chronic kidney disease (CKD) and hyperparathyreosis. ..." | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| A. U. Kulikov, I. A. Komarov | ||
| "... Currently, chronic obstructive pulmonary disease (COPD) is a 5-largest cause of death worldwide ..." | ||
| Vol 8, No 2 (2015) | MAGNESIUM DEFICIENCY OF PATIENTS WITH HORMONE DEPENDENT DISEASES: PHARMACOEPIDEMIOLOGICAL PROFILE AND LIFE QUALITY ASSESSMENT | Abstract similar documents |
| Dmitry Vladislavovich Blinov, Juliana Vladimirovna Zimovina, Elena Anatol'evna Sandakova, Tat'yana Igorevna Ushakova | ||
| "... is more studied and known than in gynecology. Prevalence of MD in patients with gynecological diseases ..." | ||
| Vol 9, No 4 (2016) | PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) | Abstract similar documents |
| D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov | ||
| "... Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important problem ..." | ||
| Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract similar documents |
| E. A. Pyadushkina | ||
| "... ) and moderate or severe active Crohn’s disease (CT) with an unsatisfactory response, loss of response ..." | ||
| Vol 10, No 1 (2017) | THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT | Abstract similar documents |
| V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova | ||
| "... , stimulates medical experts to closely study the epidemiology of non-alcoholic fatty liver disease (NAFLD ..." | ||
| 1 - 50 of 176 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
